by Jason Farmer | May 22, 2026 | Financial Oversight
The USPSTF lowered the screening start age to 45 in 2021. Five years later, many GI practices still have not realigned their scheduling model or their patient financial communication to match the changed demand. Key TakeawaysThe 2021 USPSTF update lowered the...
by Jason Farmer | May 13, 2026 | Financial Oversight
Between November 2025 and April 2026 the self-pay price of the category dropped from roughly $1,100 to $1,350 a month down to the $300s. If your program earned on the spread, the spread is gone. Key TakeawaysThe White House announced in November 2025 that Wegovy would...
by Jason Farmer | May 11, 2026 | Financial Oversight
More than half of hospitals now pay an anesthesia subsidy, and the number is rising. Whether your group is negotiating its first stipend or renewing an existing one, the hospital across the table has a CFO model. You need one too. Key TakeawaysA 2024 Health Affairs...
by Jason Farmer | Apr 23, 2026 | Financial Oversight
In-office infusion can be a meaningful revenue line for a neurology practice, and it carries compliance and cash-flow risks that a spreadsheet projection rarely captures. Here is the full picture. Key TakeawaysBuy-and-bill margin on Medicare Part B drugs is typically...
by Jason Farmer | Apr 16, 2026 | Financial Oversight
Medicare Advantage plans made nearly 53 million prior authorization determinations in 2024, and denial rates for interventional pain procedures are rising. The practices that manage this well have built it into operations, not into exception handling. Key...
by Jason Farmer | Apr 8, 2026 | Financial Oversight
CMS raised the conversion factor for 2026. That is not the number that decides whether your clinic makes money. Three reductions applied after the fee schedule are. Key TakeawaysFor CY 2026 CMS finalized two conversion factors for the first time: $33.57 for qualifying...
